FindTrial
Sign In

The research on the role of non-resolving inflammation regulatory network CCL18 and syndrom of TCM in different pathological stages of chronic gastritis associated with Helicobacter pylori

The research on the role of non-resolving inflammation regulatory network CCL18 in the early process from chronic gastritis associated with Helicobacter pylori to gastric cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCS-14004401
Enrollment
Unknown
Registered
2014-03-11
Start date
2014-03-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic gastritis and gastric cancer

Interventions

Four groups:Nil

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients of chronic gastritis made definitely diagnosis by electronic gastroscopy and pathological examination; 2. Aged 18 to 75 years old; 3. The informed consent form is needed; 4. Patients in stable condition; 5. Patients without taking non-steroidal anti-inflammatory drugs within one month.

Exclusion criteria

Exclusion criteria: 1. Clinical information and sample of patients is not complete; 2. Patients with inflammatory or autoimmune diseases such as ulcer, fever, diabetes, hepatitis and so on.

Design outcomes

Primary

MeasureTime frame
CCL18;ARF6;ACAP4;Ezrin;Endoscopic and pathological diagnosis;Helicobacter pylor;—

Secondary

MeasureTime frame
syndromes of TCM;IL-1Bß;E-cadherin;—

Countries

China

Contacts

Public ContactDing Xia

Beijing University of Chinese Medicine

dingx@bucm.edu.cn+86 13611184842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026